COMMUNIQUÉS West-GlobeNewswire

Nicox et Kowa signent un accord clé pouvant atteindre jusqu’à 191,5 millions d’euros pour les droits exclusifs du traitement du glaucome NCX 470 aux Etats-Unis et dans l’ensemble des territoires non-licenciés
17/07/2025
Communiqué de presse Nicox et Kowa signent un accord clé pouvant atteindre jusqu’à 191,5 millions d’euros pour les droits exclusifs du traitement du glaucome NCX 470 aux Etats-Unis et dans l’ensemble des territoires non [...]
Nicox and Kowa Sign Key Agreement worth up to €191.5 million for Exclusive Rights to Glaucoma Treatment NCX 470 in U.S. and all Unlicensed Territories
17/07/2025
Press Release Nicox and Kowa Sign Key Agreement worth up to €191.5 million for Exclusive Rights to Glaucoma Treatment NCX 470 in U.S. and all Unlicensed Territories €7.5 million upfront, with total potential development [...]
Pharming Group to report second quarter and first half 2025 financial results and provide business update on July 31
17/07/2025
Leiden, the Netherlands, July 17, 2025: Pharming Group N.V. (“Pharming”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) confirms that it will report its preliminary (unaudited) financial results for the second quarter and [...]
La direction de l’EAACI fait le point sur son remarquable congrès 2025 représentant un tournant décisif pour l’allergologie et l’immunologie
17/07/2025
ZURICH, 17 juill. 2025 (GLOBE NEWSWIRE) -- Le congrès 2025 de l’EAACI a fait couler beaucoup d’encre à l’appui de ses 7 600 participants et plus, de son envergure et du message fort porté par son comité directeur. Un [...]
EAACI Leadership Reflects on Record-Breaking Congress 2025: A Pivotal Moment for Allergy and Immunology
17/07/2025
ZURICH, July 17, 2025 (GLOBE NEWSWIRE) -- With over 7,600 delegates in attendance, EAACI Congress 2025 made headlines not just for its scale but for the powerful message delivered by its leadership. Now, one month after [...]
Female Muscle Growth: How CrazyBulk’s Natural Legal Steroids Are Reshaping Muscle Building Supplements For Bodybuilding Women
16/07/2025
Discover how CrazyBulk’s natural legal steroids are transforming muscle building supplements for bodybuilding women seeking safe, effective female muscle growth. New York City, NY, July 16, 2025 (GLOBE NEWSWIRE) -- In a [...]
60 Degrees Pharmaceuticals Announces Closing of up to $10 Million Public Offering
16/07/2025
$5 million received upfront with up to an additional $5 million of potential aggregate gross proceeds upon the exercise in full of short-term warrants WASHINGTON, July 16, 2025 (GLOBE NEWSWIRE) -- 60 Degrees [...]
Anika to Issue Second Quarter 2025 Financial Results on Wednesday, July 30, 2025
16/07/2025
BEDFORD, Mass., July 16, 2025 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue its second quarter [...]
Outset Medical to Report Second Quarter 2025 Financial Results on Wednesday, August 6, 2025
16/07/2025
SAN JOSE, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
Glass House Brands Announces Preferred Equity Refinancing
16/07/2025
LONG BEACH, Calif. and TORONTO, July 16, 2025 (GLOBE NEWSWIRE) -- Glass House Brands Inc. (“Glass House” or the “Company”) (CBOE CA: GLAS.A.U) (CBOE CA: GLAS.WT.U) (OTCQX: GLASF) (OTCQX:GHBWF), one of the fastest- [...]
Vincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution Proposal
16/07/2025
Revised Potential Distribution Range of $0.03 to $0.07 per share based on current estimates and assumptions Failure to approve Dissolution Proposal on a timely basis will result in continued operating costs and further [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
16/07/2025
CONSHOHOCKEN, Pa., July 16, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
Senseonics Holdings, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call for August 6, 2025 at 4:30 P.M. Eastern Time
16/07/2025
GERMANTOWN, Md., July 16, 2025 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose [...]
BriaCell Therapeutics Announces Closing of $15 million Public Offering
16/07/2025
PHILADELPHIA and VANCOUVER, British Columbia, July 16, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company [...]
Teladoc Health to Announce Second Quarter 2025 Financial Results
16/07/2025
NEW YORK, July 16, 2025 (GLOBE NEWSWIRE) -- Teladoc Health Inc. (NYSE: TDOC), the global leader in virtual care, announced that it will release second quarter 2025 results on Tuesday, July 29, 2025, after the market [...]
Avicanna Announces Closing of Non-Brokered Private Placement
16/07/2025
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF UNITED STATES SECURITIES LAWS TORONTO, July 16 [...]
NKGen Biotech Announces New Funding to Regain Compliance with Reporting Obligations and Listing Standards
16/07/2025
Funding in the amount of $2.0M from Japanese strategic investor, in the form of common equity PIPE with warrants. New funding provides for necessary resources to regain compliance with reporting obligations and listing [...]
Virbac: au premier semestre 2025, le chiffre d'affaires a enregistré une solide croissance de +5,6% à taux de change et périmètre constants
16/07/2025
CHIFFRES CLÉS Chiffre d’affaires du 1 er semestre 2025 738,3 M€ Croissance à taux de change et périmètre constants 1 +5,6% dont animaux de compagnie +7,1% animaux d’élevage +5,1% Croissance à taux de change constants 2 [...]
Virbac: in the first half of 2025, revenue recorded solid growth of +5.6% at constant exchange rates and scope of consolidation
16/07/2025
KEY FIGURES Revenue in first half of 2025 €738.3M Growth at constant exchange rates and scope 1 +5.6 including companion animals +7.1% farm animals +5.1% Growth at constant exchange rates 2 +7.8% Overall change +5.0% [...]

Pages